![Mark Rosenblum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Rosenblum
Vorstandsvorsitzender bei
Salarius Pharmaceuticals LLC
Vermögen: 6 909 $ am 31.07.2026
Profil
Mark J.
Rosenblum currently serves as Executive VP, Chief Executive & Financial Officer at Salarius Pharmaceuticals LLC starting in 2025.
He is a Member of The American Institute of Certified Public Accountants.
Since 2019, he has been Chief Financial Officer & Executive Vice President at Decoy Therapeutics, Inc. Formerly, he was Chairman & Chief Executive Officer at ActiveCare, Inc. from 2017 to 2019.
From 1985 to 2003, he was Chief Accounting Officer, VP & Controller at Wellman, Inc. He was Chief Financial Officer & Secretary at Hemobiotech, Inc. from 2005 to 2009.
From 2010 to 2014, he held the roles of Chief Financial Officer, Secretary & Senior VP at Advaxis, Inc. He was Chief Financial Officer at Vaneltix Pharma, Inc. from 2014 to 2015.
He was Chief Executive & Financial Officer at Salarius Pharmaceuticals, Inc. in 2025.
He was a Member of the South Carolina Association of Certified Public Accountants.
Education includes undergraduate and graduate degrees from the University of South Carolina.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,26 % | 20.07.2026 | 1.681 ( 0,26 % ) | 6 909 $ | 31.07.2026 |
Aktive Positionen von Mark Rosenblum
| Unternehmen | Position | Beginn |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Vorstandsvorsitzender | 17.08.2025 |
Ehemalige bekannte Positionen von Mark Rosenblum
| Unternehmen | Position | Ende |
|---|---|---|
| ACTIVECARE INC | Vorstandsvorsitzender | 01.03.2019 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Finanzdirektor/CFO | 01.07.2015 |
| AYALA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.04.2014 |
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology Licenses a blood substitute | Finanzdirektor/CFO | 31.12.2009 |
Wellman, Inc.
 Wellman, Inc. Chemicals: SpecialtyProcess Industries Manufactures plastic packaging, fibers and engineering resins | Comptroller/Controller/Auditor | 01.06.2003 |
Ausbildung von Mark Rosenblum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Wellman, Inc.
Wellman, Inc. Chemicals: SpecialtyProcess Industries Manufactures plastic packaging, fibers and engineering resins | Process Industries |
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology Licenses a blood substitute | Health Technology |
ActiveCare, Inc.
 ActiveCare, Inc. Medical SpecialtiesHealth Technology Operates as a wellness company and provides healthcare services | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
South Carolina Association of Certified Public Accountants
 South Carolina Association of Certified Public Accountants The South Carolina Association of Certified Public Accountants is a professional organization based in West Columbia, SC. It serves as a hub for certified public accountants in South Carolina, providing resources, support, and networking opportunities to its members. The association aims to promote the highest standards of professionalism and ethics in the accounting industry, while also advocating for the interests of its members. Through various educational programs, events, and publications, the South Carolina Association of Certified Public Accountants strives to enhance the knowledge and skills of its members and contribute to the growth and success of the accounting profession in the state. | |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Health Technology |
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Salarius Pharmaceuticals, Inc.
 Salarius Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on developing treatment for cancer | Health Technology |
